This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07858/identifier/pdb/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07858/identifier/pubchem-compound/
n6http://linked.opendata.cz/resource/drugbank/drug/DB07858/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07858/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07858/identifier/chemspider/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07858
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n13:DB07858 n14:DB07858
dcterms:title
(2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE
adms:identifier
n6:99444329 n8:GVO n9:15602982 n10:13078463 n11:DB07858
n3:IUPAC-Name
n4:271B4620-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4626-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4625-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4622-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4623-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4624-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B461E-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B461F-363D-11E5-9242-09173F13E4C5 n4:271B461C-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B461D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B462C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B462D-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4627-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4628-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B462A-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4629-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B462B-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4632-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4634-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4635-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4631-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4630-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4633-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4621-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B462E-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B462F-363D-11E5-9242-09173F13E4C5